Medicare will only cover Aduhelm for patients in clinical trials
Apr 08, 2022
The decision is meant to protect patients while gathering more clinical data on whether the medication actually helps slow declines in thinking.
Improved dementia diagnosing can lead to better advanced care planning: study
By
Kimberly Bonvissuto
Apr 04, 2022
Medical providers are diagnosing Alzheimer’s disease and related dementias in older adults more frequently than in the past, providing opportunities for better advanced care planning, according to the...
Alzheimer’s disease, related dementia diagnoses up in Medicare decedents
Apr 01, 2022
The percentage of older U.S. decedents with a diagnosis of Alzheimer’s disease and related dementias increased significantly from 2004 to 2017.
Psychotropic meds tied to risk for post-COVID dementia in seniors
Mar 25, 2022
The one-year incidence rate of post-COVID dementia was 12.7% in adults ≥65 years hospitalized with COVID-19.
Folate deficiency in seniors may increase dementia, mortality risks
Mar 17, 2022
But evidence suggests that reverse causation may play a role in the links between serum folate deficiency and dementia, all-cause mortality.
Dementia to cost nation $321 billion this year, Alzheimer’s Association says
By
Kimberly Bonvissuto
Mar 16, 2022
This year, Alzheimer’s and other dementias will cost the nation $321 billion, increasing to $1 trillion by 2050, according to a report released Tuesday by the Alzheimer’s Association.
Excess mortality seen for seniors with Alzheimer’s disease, dementia in COVID-19
Mar 08, 2022
Enrollees with Alzheimer’s disease and related dementias had increased adjusted mortality, especially for Asian, Black and Hispanic populations.
Stable body mass index tied to slower cognitive decline in older adults
Jan 25, 2022
The findings were seen regardless of whether a person has normal, overweight or obese body mass index at baseline.
Should residents’ access to Alzheimer’s drug be restricted?
By
Lois A. Bowers
Jan 18, 2022
You have until Feb. 10 to share your comments with CMS about its recent proposal related to Alzheimer’s drug aducanumab (Aduhelm).
Donepezil tied to risk for overactive bladder
Jan 13, 2022
The risk for overactive bladder varies across individual cholinesterase inhibitor drugs.